Symbol: |
LANCL2
|
Description: |
LanC lantibiotic synthetase component C-like 2 (bacterial) [Source:HGNC Symbol;Acc:6509]
|
Location: |
Chr7:55433141-55501435[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:80
Gene |
Compound |
Gen_sig |
Exp_pattern |
LANCL2 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.011 |
Down |
LANCL2 |
Cyclo-C |
0.001 |
Up |
LANCL2 |
AT 116, benzylamine salt |
0.034 |
Down |
LANCL2 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.014 |
Down |
LANCL2 |
STREPTOVARICIN G |
0.033 |
Down |
LANCL2 |
NSC 164887 |
0.046 |
Up |
LANCL2 |
Bromocriptine methanesulfonate |
0.005 |
Up |
LANCL2 |
NSC 175296 |
0.027 |
Up |
LANCL2 |
NSC 29182 |
0.048 |
Up |
LANCL2 |
NSC 294526 |
0.019 |
Up |
LANCL2 |
Piperidine, 2,6-diphenyl-1-methyl-4-[(phenylmethoxy)imino]-, cis- |
0.038 |
Up |
LANCL2 |
PHYTOENE |
0.026 |
Up |
LANCL2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.044 |
Down |
LANCL2 |
Naphtho[2,1-b]furan-6,9-dione, 7-chloro-1,2-dihydro- 5-hydroxy-2-methoxy-2,4-dimethyl- |
0.045 |
Down |
LANCL2 |
ANTINEOPLASTIC-625543 |
0.049 |
Up |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:41
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
LANCL2 |
ENST00000254770 |
hsa-mir-548b-3p |
Chr6:119390227-119390248[-] |
LANCL2 |
ENST00000254770 |
hsa-mir-647 |
Chr20:62574044-62574064[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|